av/mesoblast--big.svg

NASDAQ:MESO

Mesoblast Ltd

  • Stock

1.84

−1.86%

−0.03

USD last updated 13/08 01:59:42

Last Close

1.88

02/05 06:10

Market Cap

1.26B

Beta: 2.53

Volume Today

3.53M

Avg: 135.50K

PE Ratio

−3.13

PFCF: −2.83

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is bas...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.6-0.4-0.20.22020-02-262022-02-242023-12-262024-06-062024-07-29

    Revenue (Estimate*)

    2M4M6M8M10M12M2020-02-262022-02-242023-12-262024-06-062024-07-29

    *Estimate based on analyst consensus